PF-4 Antibodies

Santa Cruz Biotechnology features a diverse variety of PF-4 monoclonal antibodies for research focused on understanding platelet factor 4 (PF-4) in various biological processes. PF-4 Antibodies are validated for techniques including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PF-4 is a chemokine secreted by activated platelets and plays a crucial role in modulating inflammation and wound healing. The chemokine actively participates in regulating angiogenesis while demonstrating significant involvement in cardiovascular diseases and cancer. Understanding PF-4 function continues to be a key focus in developing new therapeutic approaches. Researchers investigating PF-4 can explore its molecular interactions and cellular pathways through multiple experimental applications. Current studies of PF-4 reveal its importance in both normal physiological processes and disease states. Ongoing research with PF-4 has highlighted its potential as a therapeutic target in various medical conditions. Santa Cruz Biotechnology monoclonal antibodies for PF-4 research support scientists worldwide in advancing our understanding of this significant chemokine and its therapeutic applications.